"Cystadenocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
| Descriptor ID |
D003536
|
| MeSH Number(s) |
C04.557.470.200.025.480 C04.557.470.590.480
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cystadenocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Cystadenocarcinoma".
This graph shows the total number of publications written about "Cystadenocarcinoma" by people in this website by year, and whether "Cystadenocarcinoma" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Cystadenocarcinoma" by people in Profiles.
-
Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann Surg. 2010 May; 251(5):937-45.
-
Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity. Anticancer Drugs. 2000 Aug; 11(7):565-8.
-
Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer. Cancer. 1993 Jun 15; 71(12):3942-6.
-
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. Am J Obstet Gynecol. 1991 Nov; 165(5 Pt 1):1356-62.
-
Reactivity of polyclonal and two monoclonal antibodies with cell subsets isolated from cystic fluids of ovarian serous neoplasms. Tumori. 1990 Oct 31; 76(5):505-10.
-
Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum. Am J Obstet Gynecol. 1985 Aug 15; 152(8):1003-10.
-
Recombinant leukocyte alpha interferon in advanced ovarian carcinoma. Cancer Treat Rep. 1985 Jul-Aug; 69(7-8):895-6.
-
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. Am J Obstet Gynecol. 1984 Jul 01; 149(5):553-9.
-
Somatic activation of rasK gene in a human ovarian carcinoma. Science. 1984 Feb 17; 223(4637):698-701.
-
Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms. Int J Cancer. 1983 Nov 15; 32(5):547-54.